Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (vol 123, pg 26, 2020)

被引：0
|
作者：
Gelsomino, Francesco [1 ]
Tiseo, Marcello [1 ]
Barbieri, Fausto [1 ]
Riccardi, Ferdinando [1 ]
Cavanna, Luigi [1 ]
Frassoldati, Antonio [1 ]
Delmonte, Angelo [1 ]
Longo, Lucia [1 ]
Dazzi, Claudio [1 ]
Cinieri, Saverio [1 ]
Colantonio, Ida [1 ]
Sperandi, Francesca [1 ]
Lamberti, Giuseppe [1 ]
Brocchi, Stefano [1 ]
Tofani, Lorenzo [1 ]
Boni, Luca [1 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
来源：
BRITISH JOURNAL OF CANCER | 2021年 / 125卷 / 02期
关键词：
D O I：
10.1038/s41416-021-01439-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [31] Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: KTOSG Trial 1301
    Sakata, Shinya
    Saeki, Sho
    Okamoto, Isamu
    Otsubo, Kohei
    Komiya, Kazutoshi
    Morinaga, Ryotaro
    Yoneshima, Yasuto
    Koga, Yuichiro
    Enokizu, Aimi
    Kishi, Hiroto
    Hirosako, Susumu
    Yamaguchi, Emi
    Aragane, Naoko
    Fujii, Shinji
    Harada, Taishi
    Iwama, Eiji
    Nakanishi, Yoichi
    Kohrogi, Hirotsugu
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S923 - S923
  • [32] Phase II study of nab-paclitaxel plus carboplatin for patients with non-small-cell lung cancer and interstitial lung disease
    Kenmotsu, Hirotsugu
    Yoh, Kiyotaka
    Mori, Keita
    Ono, Akira
    Baba, Tomohisa
    Fujiwara, Yutaka
    Yamaguchi, Ou
    Ko, Ryo
    Okamoto, Hiroaki
    Yamamoto, Nobuyuki
    Ninomiya, Takashi
    Ogura, Takashi
    Kato, Terufumi
    CANCER SCIENCE, 2019, 110 (12) : 3738 - 3745
  • [33] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion
    Motohiro Tamiya
    Akihiro Tamiya
    Hidekazu Suzuki
    Yoshihiko Taniguchi
    Kanako Katayama
    Shojiro Minomo
    Keiko Nakao
    Naoko Takeuchi
    Yoshinobu Matsuda
    Yujiro Naito
    Takayuki Shiroyama
    Norio Okamoto
    Kyoichi Okishio
    Toru Kumagai
    Shinji Atagi
    Fumio Imamura
    Tomonori Hirashima
    Investigational New Drugs, 2021, 39 : 1106 - 1112
  • [34] A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer: Results of NICE Salvage Study
    Kogure, Y.
    Niwa, T.
    Yoshioka, H.
    Saka, H.
    Hata, A.
    Katakami, N.
    Ozawa, Y.
    Matsuo, N.
    Hoshino, T.
    Wakuda, K.
    Kenmotsu, H.
    Takahashi, T.
    Nosaki, K.
    Takenoyama, M.
    Tajima, M.
    Takahashi, K.
    Ando, M.
    Yamamoto, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S355 - S356
  • [35] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
    Hirose, Takashi
    Nakashima, Masanao
    Shirai, Takao
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    LUNG CANCER, 2011, 73 (03) : 345 - 350
  • [36] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Hisashi Tanaka
    Kageaki Taima
    Takeshi Morimoto
    Yoshihito Tanaka
    Masamichi Itoga
    Kunihiko Nakamura
    Akihito Hayashi
    Mika Kumagai
    Hideo Yasugahira
    Megumi Mikuniya
    Koichi Okudera
    Shingo Takanashi
    Sadatomo Tasaka
    BMC Cancer, 17
  • [37] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    BMC CANCER, 2017, 17
  • [38] Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S922 - S922
  • [39] A phase I/II study of Carboplatin plus Nab-Paclitaxel in PS 2 pts with advanced non-small-cell lung cancer
    Niwa, Takashi
    Nakashima, Kazuhisa
    Yoshioka, Hiroshige
    Iwamoto, Yasuo
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Mori, Keita
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations
    Baik, Christina
    Goulart, Bernardo
    Nguyen, Katherine
    Lee, Sylvia
    Eaton, Keith
    Chow, Laura
    Rodriguez, Cristina
    Santana-Davila, Rafael
    Wood, Rebecca
    Martins, Renato
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1227
12345